Skip to main content

Peer Review reports

From: FRAGMATIC: A randomised phase III clinical trial investigating the effect of fragmin® added to standard therapy in patients with lung cancer

Original Submission
9 Apr 2009 Submitted Original manuscript
3 Jun 2009 Reviewed Reviewer Report - Mario Furlanut
5 Jun 2009 Reviewed Reviewer Report - Andrew Vickers
28 Jul 2009 Author responded Author comments - Gareth Griffiths
Resubmission - Version 2
28 Jul 2009 Submitted Manuscript version 2
5 Aug 2009 Reviewed Reviewer Report - Andrew Vickers
15 Sep 2009 Author responded Author comments - Gareth Griffiths
Resubmission - Version 3
15 Sep 2009 Submitted Manuscript version 3
15 Sep 2009 Author responded Author comments - Gareth Griffiths
Resubmission - Version 4
15 Sep 2009 Submitted Manuscript version 4
24 Sep 2009 Author responded Author comments - Gareth Griffiths
Resubmission - Version 5
24 Sep 2009 Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
29 Sep 2009 Author responded Author comments - Gareth Griffiths
Resubmission - Version 7
29 Sep 2009 Submitted Manuscript version 7
Publishing
6 Oct 2009 Editorially accepted
6 Oct 2009 Article published 10.1186/1471-2407-9-355

You can find further information about peer review here.

Back to article page